ATE356867T1 - Epitopen aus dem epha2-antigen - Google Patents

Epitopen aus dem epha2-antigen

Info

Publication number
ATE356867T1
ATE356867T1 AT03740654T AT03740654T ATE356867T1 AT E356867 T1 ATE356867 T1 AT E356867T1 AT 03740654 T AT03740654 T AT 03740654T AT 03740654 T AT03740654 T AT 03740654T AT E356867 T1 ATE356867 T1 AT E356867T1
Authority
AT
Austria
Prior art keywords
epitopes
epha2 antigen
epha2
antigen
polynucleotide
Prior art date
Application number
AT03740654T
Other languages
English (en)
Inventor
Kostas Kosmatopoulos
Pedro Alves
Original Assignee
Inst Nat Sante Rech Med
Roussy Inst Gustave
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Nat Sante Rech Med, Roussy Inst Gustave filed Critical Inst Nat Sante Rech Med
Application granted granted Critical
Publication of ATE356867T1 publication Critical patent/ATE356867T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT03740654T 2002-04-23 2003-04-23 Epitopen aus dem epha2-antigen ATE356867T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0205048A FR2838742B1 (fr) 2002-04-23 2002-04-23 Epitopes t de l'antigene epha2

Publications (1)

Publication Number Publication Date
ATE356867T1 true ATE356867T1 (de) 2007-04-15

Family

ID=28686278

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03740654T ATE356867T1 (de) 2002-04-23 2003-04-23 Epitopen aus dem epha2-antigen

Country Status (11)

Country Link
US (1) US20060034856A1 (de)
EP (1) EP1497417B1 (de)
AT (1) ATE356867T1 (de)
AU (1) AU2003262810A1 (de)
CA (1) CA2482930C (de)
DE (1) DE60312502T2 (de)
DK (1) DK1497417T3 (de)
ES (1) ES2283791T3 (de)
FR (1) FR2838742B1 (de)
PT (1) PT1497417E (de)
WO (1) WO2003091383A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005012350A2 (en) 2003-07-30 2005-02-10 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Epha2 t-cell epitope agonists and uses therefor
US20120052080A1 (en) 2004-09-21 2012-03-01 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Interleukin-13 receptor alpha 2 peptide-based brain cancer vaccines
US7612162B2 (en) * 2004-09-21 2009-11-03 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Peptide analogs capable of enhancing stimulation of a glioma-specific CTL response
KR101363252B1 (ko) * 2005-02-04 2014-02-13 레이븐 바이오테크놀로지스, 인코퍼레이티드 Ｅｐｈａ2에 결합하는 항체 및 그것의 사용방법
DE602006006046D1 (de) 2005-05-09 2009-05-14 Vaxon Biotech Verwendung nativer peptide und deren optimierter derivate zur impfung
SI2199390T1 (sl) 2007-08-30 2017-02-28 Daiichi Sankyo Company, Limited Proti-epha2 protitelo
EP3855184B1 (de) * 2012-03-19 2023-12-27 Stemline Therapeutics Inc. Verfahren zur behandlung und überwachung eines karzinomstatus
RS62406B1 (sr) 2012-05-16 2021-10-29 Stemline Therapeutics Inc Vakcine protiv kancera sa ciljanim delovanjem na matične ćelije kancera
TWI505113B (zh) * 2014-03-18 2015-10-21 Vivotek Inc 監視系統及其影像搜尋方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6323016B1 (en) * 2000-06-09 2001-11-27 Pe Corporation (Ny) Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
US20040037840A1 (en) * 2000-10-27 2004-02-26 Beier Anne Mette Novel therapeutic vaccine formulations
JP2005535289A (ja) * 2002-02-15 2005-11-24 ミレニアム・ファーマシューティカルズ・インコーポレイテッド １４１４分子、１４８１分子、１５５３分子、３４０２１分子、１７２０分子、１６８３分子、１５５２分子、１６８２分子、１６７５分子、１２８２５分子、９９５２分子、５８１６分子、１０００２分子、１６１１分子、１３７１分子、１４３２４分子、１２６分子、２７０分子、３１２分子、１６７分子、３２６分子、１８９２６分子、６７４７分子、１７９３分子、１７８４分子または２０４５分子を用いて、ａｉｄｓおよびｈｉｖ関連障害を処置するための方法および組成物

Also Published As

Publication number Publication date
WO2003091383A3 (fr) 2004-04-01
WO2003091383A2 (fr) 2003-11-06
FR2838742A1 (fr) 2003-10-24
AU2003262810A1 (en) 2003-11-10
DE60312502D1 (de) 2007-04-26
DE60312502T2 (de) 2007-10-31
EP1497417B1 (de) 2007-03-14
DK1497417T3 (da) 2007-06-25
PT1497417E (pt) 2007-06-01
US20060034856A1 (en) 2006-02-16
CA2482930A1 (fr) 2003-11-06
FR2838742B1 (fr) 2004-07-09
ES2283791T3 (es) 2007-11-01
EP1497417A2 (de) 2005-01-19
AU2003262810A8 (en) 2003-11-10
CA2482930C (fr) 2013-08-13

Similar Documents

Publication Publication Date Title
BR122018016045B8 (pt) proteína variante otimizada
BRPI0314814C1 (pt) anticorpo compreendendo uma variante de fc
CY1115147T1 (el) Εξουδετερωτικα αντισωματα που εχουν ειδικοτητα για ανθρωπινη il-17
ATE426412T1 (de) Adjuvante influenza-vakzine
BRPI0517973B8 (pt) métodos para purificar o fsh recombinante
MXPA04003333A (es) Remodelado y glicoconjugacion de peptidos.
AR060998A1 (es) Anticuerpo monoclonal anti cd40 humana antagonista
ATE542829T1 (de) Impfstoff
DK1362109T3 (da) Rekombinante oligomere protein-komplekser med foröget immunogent potentiale
MX338940B (es) Identificacion de epitopos ige novedosos.
CY1107681T1 (el) Χρηση παραγωγων τροπινεστερα για την παραγωγη φαρμακευτικων μεσων
DE60312502D1 (de) Epitopen aus dem epha2-antigen
EA200701305A1 (ru) Иммуногенные композиции, содержащие циклические пептиды, полученные из бета-амилоидного пептида
NO20081043L (no) Vaksine for fisk
ATE517340T1 (de) Sätze gegen kurze epitope gerichteter digitaler antikörper sowie diese verwendende verfahren
DE60228971D1 (de) Peptide aus dem g-protein des respiratorischen synzytialvirus und deren verwendung in einem impfstoff
DK1397380T3 (da) Multipelt antigent peptid, der udviser flere kopier af en epitop af et plaquedannende polypeptid, og fremgangmåder til anvendelse deraf
WO2004030616A3 (en) Ii-KEY/ANTIGENIC EPITOPE HYBRID PEPTIDE VACCINES
NO20062579L (no) Preparater som omfatter melittin-avledede peptider og fremgangsmate for styrking av immunresponser mot malantigener
DE60219215D1 (de) Prionen-bindende peptidsequenzen
DK1625152T3 (da) Peptider, som modulerer sktiviteten af Engrailed-transskriptionsfaktoren
BRPI0416201A (pt) métodos para purificação de toxina coqueluche e peptìdios neles utilizáveis
EA200400897A1 (ru) Иммуногенные композиции из вариабельных пептидных эпитопов и способ их получения
CY1109904T1 (el) Προαγωγεας της il-18bp, η παρασκευη και χρηση του
ATE334652T1 (de) Kosmetische zubereitungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1497417

Country of ref document: EP